Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Akinaga, S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 35 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bagatell, R; Khan, O; Paine-Murrieta, G; Taylor, CW; Akinaga, S; Whitesell, L
      Destabilization of steroid receptors by heat shock protein 90-binding drugs: A ligand-independent approach to hormonal therapy of breast cancer

      CLINICAL CANCER RESEARCH
    2. Abe, S; Kubota, T; Otani, Y; Furukawa, T; Watanabe, M; Kumai, K; Akiyama, T; Akinaga, S; Kitajima, M
      UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery

      JAPANESE JOURNAL OF CANCER RESEARCH
    3. Nakai, R; Kakita, S; Asai, A; Chiba, S; Akinaga, S; Mizukami, T; Yamashita, Y
      Chrolactomycin, a novel antitumor antibiotic produced by Streptomyces sp.

      JOURNAL OF ANTIBIOTICS
    4. Bagatell, R; Paine-Murrieta, GD; Taylor, CW; Pulcini, EJ; Akinaga, S; Benjamin, IJ; Whitesell, L
      Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of Hsp90-binding agents

      CLINICAL CANCER RESEARCH
    5. Kanazawa, J; Ohta, S; Shitara, K; Fujita, F; Fujita, M; Hanai, N; Akinaga, S; Okabe, M
      Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    6. Akinaga, S; Sugiyama, K; Akiyama, T
      UCN-01 (7-hydroxystaurosporine) and other indolocarbazole compounds: a newgeneration of anti-cancer agents for the new century?

      ANTI-CANCER DRUG DESIGN
    7. Nakai, R; Ogawa, H; Asai, A; Ando, K; Agatsuma, T; Matsumiya, S; Akinaga, S; Yamashita, Y; Mizukami, T
      UCS1025A, a novel antibiotic produced by Acremonium sp.

      JOURNAL OF ANTIBIOTICS
    8. Sugiyama, K; Shimizu, M; Akiyama, T; Tamaoki, T; Yamaguchi, K; Takahashi, R; Eastman, A; Akinaga, S
      UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation

      INTERNATIONAL JOURNAL OF CANCER
    9. Shinohara, H; Zhou, J; Yoshikawa, K; Yazumi, S; Ko, K; Yamaoka, Y; Mizukami, T; Yoshida, T; Akinaga, S; Tamaoki, T; Motoda, H; Benedict, WF; Takahashi, R
      Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis

      BRITISH JOURNAL OF CANCER
    10. Shiotsu, Y; Neckers, LM; Wortman, I; An, WG; Schulte, TW; Soga, S; Murakata, C; Tamaoki, T; Akinaga, S
      Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex

      BLOOD
    11. Shiotsu, Y; Yamashita, K; Kanai, F; Ikuina, Y; Murakata, C; Teramura, M; Mizoguchi, H; Tamaoki, T; Akinaga, S
      Chemoprotective effects of KF41399, a derivative of carbazole compounds, on nimustine-induced thrombocytopenia

      BLOOD
    12. Akiyama, T; Shimizu, M; Okabe, W; Tamaoki, T; Akinaga, S
      Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycleprogression and CDC2 cyclin B-1 regulation in A431 cells synchronized at Mphase by nocodazole

      ANTI-CANCER DRUGS
    13. Akiyama, T; Sugiyama, K; Shimizu, M; Tamaoki, T; Akinaga, S
      G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation

      JAPANESE JOURNAL OF CANCER RESEARCH
    14. Schulte, TW; Akinaga, S; Murakata, T; Agatsuma, T; Sugimoto, S; Nakano, H; Lee, YS; Simen, BB; Argon, Y; Felts, S; Toft, DO; Neckers, LM; Sharma, SV
      Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones

      MOLECULAR ENDOCRINOLOGY
    15. Kurata, N; Kuwabara, T; Tanii, H; Fuse, E; Akiyama, T; Akinaga, S; Kobayashi, H; Yamaguchi, K; Kobayashi, S
      Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor,UCN-01

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    16. Sugiyama, K; Akiyama, T; Shimizu, M; Tamaoki, T; Courage, C; Gescher, A; Akinaga, S
      Decrease in susceptibility toward induction of apoptosis and alteration inG(1) checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-hydroxystaurosporine)

      CANCER RESEARCH
    17. Soga, S; Neckers, LM; Schulte, TW; Shiotsu, Y; Akasaka, K; Narumi, H; Agatsuma, T; Ikuina, Y; Murakata, C; Tamaoki, T; Akinaga, S
      KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumoractivity via selective depletion of Hsp90 binding signaling molecules

      CANCER RESEARCH
    18. SCHULTE TW; AKINAGA S; SOGA S; SULLIVAN W; STENSGARD B; TOFT D; NECKERS LM
      ANTIBIOTIC RADICICOL BINDS TO THE N-TERMINAL DOMAIN OF HSP90 AND SHARES IMPORTANT BIOLOGIC ACTIVITIES WITH GELDANAMYCIN

      Cell stress & chaperones
    19. KANAZAWA J; TAKAHASHI T; AKINAGA S; TAMAOKI T; OKABE M
      THE RELATIONSHIP BETWEEN THE ANTITUMOR-ACTIVITY AND THE RIBONUCLEOTIDE REDUCTASE INHIBITORY ACTIVITY OF (E)-2'-DEOXY-2'-(FLUOROMETHYLENE) CYTIDINE, MDL 101,731

      Anti-cancer drugs
    20. TAKAHASHI T; KANAZAWA J; OKABE M; AKINAGA S; TAMAOKI T
      ANTITUMOR-ACTIVITY OF HLORO-9-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL) ADENINE, A NOVEL DEOXYADENOSINE ANALOG, AGAINST HUMAN COLON-TUMOR XENOGRAFTS BY ORAL-ADMINISTRATION

      Annals of oncology
    21. TAKAHASHI T; NAKASHIMA A; KANAZAWA JJ; YAMAGUCHI K; AKINAGA S; TAMAOKI T; OKABE M
      METABOLISM AND RIBONUCLEOTIDE REDUCTASE INHIBITION OF (E)-2'-DEOXY-2'-(FLUOROMETHYLENE)CYTIDINE, MDL 101,731 IN HUMAN CERVICAL-CARCINOMA HELA S-3 CELLS

      Cancer chemotherapy and pharmacology
    22. Takahashi, T; Kanazawa, J; Akinaga, S; Tamaoki, T; Okabe, M
      Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    23. SHIOTSU Y; AKINAGA S; YAMASHITA K; MURAKATA C; TAMAOKI T; ISHIDA Y; KURIYA S; TERAMURA M; MIZOGUCHI H
      IN-VITRO AND IN-VIVO EFFECTS OF KT6352, A DERIVATIVE OF INDOLOCARBAZOLE COMPOUNDS, ON MURINE MEGAKARYOCYTOPOIESIS

      Experimental hematology
    24. Kurebayashi, J; Otsuki, T; Yamamoto, S; Kurosumi, M; Nakata, T; Akinaga, S; Sonoo, H
      A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro

      ONCOLOGY
    25. SOGA S; KOZAWA T; NARUMI H; AKINAGA S; IRIE K; MATSUMOTO K; SHARMA SV; NAKANO H; MIZUKAMI T; HARA M
      RADICICOL LEADS TO SELECTIVE DEPLETION OF RAF KINASE AND DISRUPTS K-RAS-ACTIVATED ABERRANT SIGNALING PATHWAY

      The Journal of biological chemistry
    26. FUSE E; TANII H; KURATA N; KOBAYASHI H; SHIMADA Y; TAMURA T; SASAKI Y; TANIGAWARA Y; LUSH RD; HEADLEE D; FIGG WD; ARBUCK SG; SENDEROWICZ AM; SAUSVILLE EA; AKINAGA S; KUWAHARA A; KOBASASHI S
      UNPREDICTED CLINICAL-PHARMACOLOGY OF UCN-01 CAUSED BY SPECIFIC BINDING TO HUMAN ALPHA(1)-ACID GLYCOPROTEIN

      Cancer research
    27. Sugiyama, K; Shimizu, M; Akiyama, T; Ishida, H; Okabe, M; Tamaoki, T; Akinaga, S
      Combined effect of navelbine with medroxyprogesterone acetate against human breast carcinoma MCF-7 cells in vitro

      BRITISH JOURNAL OF CANCER
    28. SASAKI T; ISHII S; SENDA M; AKINAGA S; MURAKATA C
      SYNTHESIS OF [7-BETA-METHOXY C-11] METHOXY STAUROSPORINE FOR IMAGING PROTEIN-KINASE-C LOCALIZATION IN THE BRAIN

      The Journal of nuclear medicine
    29. SAKAI Y; YOSHIDA T; TSUJITA T; OCHIAI K; AGATSUMA T; SAITOH Y; TANAKA F; AKIYAMA T; AKINAGA S; MIZUKAMI T
      GE3, A NOVEL HEXADEPSIPEPTIDE ANTITUMOR ANTIBIOTIC, PRODUCED BY STREPTOMYCES SP .1. TAXONOMY, PRODUCTION, ISOLATION, PHYSICOCHEMICAL PROPERTIES, AND BIOLOGICAL-ACTIVITIES

      Journal of antibiotics
    30. AKIYAMA T; YOSHIDA T; TSUJITA T; SHIMIZU M; MIZUKAMI T; OKABE M; AKINAGA S
      G(1) PHASE ACCUMULATION INDUCED BY UCN-01 IS ASSOCIATED WITH DEPHOSPHORYLATION OF RB AND CDK2 PROTEINS AS WELL AS INDUCTION OF CDK INHIBITOR P21 CIP1/WAF1/SDI1 IN P53-MUTATED HUMAN EPIDERMOID CARCINOMA A431 CELLS/

      Cancer research
    31. SASAKI T; ISHII SI; SENDA M; AKINAGA S; MURAKATA C
      SYNTHESIS OF [7-BETA-METHOXY C-11]METHOXY STAUROSPORINE FOR IMAGING PROTEIN-KINASE-C LOCALIZATION IN THE BRAIN

      Applied radiation and isotopes
    32. AKINAGA S; NOMURA K; GOMI K; OKABE M
      EFFECT OF UCN-01, A SELECTIVE INHIBITOR OF PROTEIN-KINASE-C, ON THE CELL-CYCLE DISTRIBUTION OF HUMAN EPIDERMOID CARCINOMA, A431-CELLS

      Cancer chemotherapy and pharmacology
    33. SUGAYA T; MIMURA Y; SHIDA Y; OSAWA Y; MATSUKUMA I; IKEDA S; AKINAGA S; MORIMOTO M; ASHIZAWA T; OKABE M; OHNO H; GOMI K; KASAI H
      6H-PYRAZOLO[4,5,1-DE]ACRIDIN-6-ONES AS A NOVEL CLASS OF ANTITUMOR AGENTS - SYNTHESIS AND BIOLOGICAL-ACTIVITY

      Journal of medicinal chemistry
    34. AKINAGA S; NOMURA K; GOMI K; OKABE M
      ENHANCEMENT OF ANTITUMOR-ACTIVITY OF MITOMYCIN-C INVITRO AND INVIVO BY UCN-01, A SELECTIVE INHIBITOR OF PROTEIN-KINASE-C

      Cancer chemotherapy and pharmacology
    35. AKINAGA S; NOMURA K; GOMI K; OKABE M
      DIVERSE EFFECTS OF INDOLOCARBAZOLE COMPOUNDS ON THE CELL-CYCLE PROGRESSION OF RAS-TRANSFORMED RAT FIBROBLAST CELLS

      Journal of antibiotics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 11:47:25